Hawaii's role in developing new Alzheimer's drug

Hawaii Pacific Neuroscience was one of the sites participating in the clinical trials for the drug Leqembi for people with early Alzheimer's disease. Leqembi is the first drug proven to

Related Keywords

Honolulu ,Hawaii ,United States ,Americans ,Robert Egge ,Joanne Pike ,Alzheimer Association ,Memory Disorders Center Alzheimer Research Unit ,Alzheimer Association Hawaii ,Drug Administration ,Centers For Medicare Medicaid Services ,Pacific Neuroscience ,Kore Liow ,Hawaii Memory Disorders Center ,Research Unit ,Hawaii Pacific ,Hawaii Island ,Memory Disorders Center ,Association Hawaii ,Medicaid Services ,Alzheimers Disease ,Hawaii Pacific Neuroscience ,Leqembi ,Memory Disorder ,Memory Loss ,Dementia ,Clinical Trials ,Alzheimers Association ,Centers For Medicare Amp Medicaid Services ,